CURES: Preparing for the New Duty-to-Consult Requirement

Effective October 2, 2018, California physicians must consult California’s PDMP (the Controlled Substance Utilization Review and Evaluation System, or CURES) – prior to prescribing Schedule II, III or IV controlled substances. The California Medical Association recently co-hosted a live CURES webinar with the California Department of Justice and the Medical Board of California regarding this new duty-to-consult requirement.

Be part of the solution.

Join the AMA today and help us lead the effort
to reverse the nation’s opioid epidemic.